Ignacio Demey
Overview
Explore the profile of Ignacio Demey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
35
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cubas Guillen J, Rojas G, Demey I, Sarasola D, Merchan Del Hierro X, Persi G, et al.
J Alzheimers Dis Rep
. 2024 May;
8(1):737-746.
PMID: 38746628
Background: Alzheimer's disease (AD) presents a significant global health challenge. Understanding the current and upcoming treatment landscape is crucial for effectively managing patients. Objective: The aim of this study was...
2.
Crivelli L, Calandri I, Suemoto C, Salinas R, Velilla L, Yassuda M, et al.
Alzheimers Dement
. 2023 May;
19(9):4046-4060.
PMID: 37204054
Introduction: Latin American Initiative for Lifestyle Intervention to Prevent Cognitive Decline (LatAm-FINGERS) is the first non-pharmacological multicenter randomized clinical trial (RCT) to prevent cognitive impairment in Latin America (LA). Our...
3.
Demey I, Ollari J, Rojas G, Bagnati P, Sarasola D, Roman F, et al.
Vertex
. 2020 Jan;
XXX(144):85-96.
PMID: 31968018
Alzheimer's disease is the most frequent cause of cognitive disorders and dementia in older adults and is considered a new epi- demic. Due to its different cognitive, behavioral and functional...
4.
Bustin J, Rojas G, Oneill S, Sarasola D, Triskier F, Urtasun M, et al.
Int J Geriatr Psychiatry
. 2019 Nov;
35(3):270-275.
PMID: 31755128
Objectives: The only recommended pharmacological treatments for specific dementias are donepezil, galantamine, rivastigmine, and memantine (recommended drugs, RD). However, other drugs without recommendations (not recommended drugs, NRD) are often used...
5.
Mendez P, Calandri I, Nahas F, Russo M, Demey I, Martin M, et al.
Arq Neuropsiquiatr
. 2018 May;
76(4):231-240.
PMID: 29742242
The Argentina-Alzheimer's disease neuroimaging initiative (Arg-ADNI) study is a longitudinal prospective cohort of 50 participants at a single institution in Buenos Aires, Argentina. Longitudinal assessments on a neuropsychological test battery...
6.
Demey I, Somale V, Allegri R
Vertex
. 2015 Jun;
25(118):437-46.
PMID: 26098823
Introduction: The term vascular cognitive impairment refers to a clinical and etiological heterogeneous group of entities that may appear as a result of brain lesions caused by vascular disease. Aim:...
7.
Gatto E, Demey I, Sanguinetti A, Parisi V, Etcheverry J, Rojas G, et al.
Arq Neuropsiquiatr
. 2014 Oct;
72(10):773-6.
PMID: 25337729
Unlabelled: Cognitive dysfunction may occur in 17-40% of patients with multiple system atrophy (MSA). It has been suggested a milder cognitive impairment in cerebellar (MSA-C) than in parkinsonian variant (MSA-P)....
8.
Saux G, Demey I, Rojas G, Feldberg C
Brain Inj
. 2014 May;
28(11):1447-54.
PMID: 24865389
Primary Objective: To examine the effect of cognitive rehabilitation therapy (CRT) on psychosocial outcomes in Argentinean patients with acquired brain injury (ABI), in connection with the time elapsed between injury...
9.
Rojas G, Demey I, Arizaga R
Medicina (B Aires)
. 2013 Jun;
73(3):213-23.
PMID: 23732196
Cognitive impairment and dementia treatment costs are significant for health systems. According to national and international guidelines, recommended drugs for treatment of dementias are cholinesterase inhibitors (donepezil, galantamine, rivastigmine) and...
10.
Allegri R, Russo M, Kremer J, Taragano F, Brusco I, Ollari J, et al.
Vertex
. 2012 Aug;
23(101):5-15.
PMID: 22880190
The symptomatic predementia phase of Alzheimer's disease (AD), known as mild cognitive impairment (MCI) is a clinical and neuropsychological condition which defines the transitional state between normal aging and dementia,...